Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Iconic Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Iconic Therapeutics

Iconic Therapeutics

Acquired

Iconic Therapeutics: A biopharmaceutical firm, founded in 2006, transforming science into human and veterinary medicines.

HQ
South San Francisco, CA, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Iconic Therapeutics, founded in 2006, is a biopharmaceutical company dedicated to transforming scientific discoveries into medicines for both human and veterinary use. The company focuses on developing treatments for acute and chronic inflammatory conditions, such as acute lung injury, vasculitis, anti-phospholipid syndrome, and inflammatory bowel disease. Additionally, Iconic Therapeutics is exploring promising opportunities in ophthalmology to address serious diseases like age-related macular degeneration (AMD).

As a wholly owned subsidiary of Endpoint Health, Iconic Therapeutics benefits from the support and resources of its parent company. The firm has made significant strides in targeting cytokine modulation for inflammation and developing innovative therapies in ophthalmology. These advancements underscore its commitment to improving patient outcomes and addressing unmet medical needs, thereby making a notable impact in the biopharmaceutical industry.

Iconic Therapeutics - Similar Companies

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Imagen Biotech logo

Imagen Biotech

Ikaria logo

Ikaria

Complexa logo

Complexa

Therini Bio logo

Therini Bio

therinibio.com

Eikonizo Therapeutics logo

Eikonizo Therapeutics

eikonizo.com

Nuon Therapeutics logo

Nuon Therapeutics

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Inflammasome Therapeutics logo

Inflammasome Therapeutics

inflam.com

Inception Sciences logo

Inception Sciences

Logical Therapeutics logo

Logical Therapeutics

Halia Therapeutics logo

Halia Therapeutics

Forward Therapeutics logo

Forward Therapeutics

forward-tx.com

EyeCyte logo

EyeCyte

eyecyte.com

Iview Therapeutics logo

Iview Therapeutics

Iconic Therapeutics - Quick Facts

Who are Iconic Therapeutics' competitors?

Companies similar to Iconic Therapeutics include Eikon Therapeutics, Imagen Biotech, Ikaria and Complexa.

When was Iconic Therapeutics founded?

Iconic Therapeutics was founded in 2002.

Where is Iconic Therapeutics' headquarters located?

Iconic Therapeutics' headquarters is located in South San Francisco, CA, US.

When was Iconic Therapeutics' last funding round?

Iconic Therapeutics' most recent funding round was for $4.1M (USD) in June 2018.

How much has Iconic Therapeutics raised to-date?

As of Jun 15, 2018, Iconic Therapeutics has raised a total of $82.8M (USD).

Iconic Therapeutics - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified